The Catevo Group

The Catevo GroupCatalysts for Business EvolutionIn the world of science, a catalyst modifies and increases the rate of a chemical reaction by providing just the right spark at just the right time. In the business world, The Catevo Group strives to do the same - to provide just the right spark at just the right time to increase an organization's ability to achieve business and operational objectives. "Catalysts, by definition, provide energy to cause reactions," explains Catevo President and CEO

Written byThe Scientist
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In the world of science, a catalyst modifies and increases the rate of a chemical reaction by providing just the right spark at just the right time. In the business world, The Catevo Group strives to do the same - to provide just the right spark at just the right time to increase an organization's ability to achieve business and operational objectives. "Catalysts, by definition, provide energy to cause reactions," explains Catevo President and CEO Dr. Mitch Javidi. "Our goal at Catevo is similar: to provide the energy needed to improve bottom-line performance."

With roots stretching back four decades, Catevo was formed in 2006 through the merger of three distinguished consulting firms: Epley Associates, Inc., a public relations consultancy founded in 1968; Digiton Corporation, a research, marketing, technology and business consulting firm; and Sideways Creative Branding, a branding and design firm focusing in interactive media.

Headquartered in North Carolina's Research ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies